Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced NSCLC × Oxaliplatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 266 Stomach Neoplasms 200 Rectal Neoplasms 178 Pancreatic Neoplasms 130 Colonic Neoplasms 111 Neoplasm Metastasis 74 Esophageal Neoplasms 62 Carcinoma, Hepatocellular 41 Neoplasms 40 Cholangiocarcinoma 35 Adenocarcinoma 32 Adenocarcinoma Of Esophagus 31 Biliary Tract Neoplasms 25 Liver Neoplasms 21 Gallbladder Neoplasms 21 Recurrence 18 Gastrointestinal Neoplasms 18 Lymphoma, Large B-Cell, Diffuse 17 Peritoneal Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 16 Esophageal Squamous Cell Carcinoma 14 Locally Advanced Rectal Cancer 11 Bile Duct Neoplasms 11 Colorectal Cancer Metastatic 8 Unspecified Adult Solid Tumor, Protocol Specific 7 Ovarian Neoplasms 7 Head and Neck Neoplasms 7 Appendiceal Neoplasms 7 Lymphoma, Extranodal NK-T-Cell 6

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡